Radiofrequency as a Therapeutic Option for Mild Post-RARP Urinary Incontinence Refractory to Pelvic Floor Rehabilitation

Ferrari I1, Maltagliati M1, Menozzi M1, Perri D1, Calcagnile T1, Costi C1, De Palma A1, Carelli C1, Maruccia S1, Sangalli N1, Pini G1, Bozzini G1

Research Type

Pure and Applied Science / Translational

Abstract Category

Male Stress Urinary Incontinence (Post Prostatectomy Incontinence)

Gold Pass video coming soon
Find out more

Abstract 297
Applied Sciences
Scientific Podium Short Oral Session 31
Friday 9th October 2026
15:00 - 15:07
Parallel Hall 4
0.10 Sydney
Capacity: 265
Rehabilitation Surgery Stress Urinary Incontinence
1. Sant'Anna Hospital - Como
Presenter
Links

Abstract

Hypothesis / aims of study
Post-prostatectomy urinary incontinence (PPI) significantly impacts the quality of life (QoL) of patients undergoing robot-assisted radical prostatectomy (RARP). While pelvic floor muscle training (PFMT) is the first-line treatment, options for mild-to-moderate incontinence refractory to rehabilitation are limited, as invasive procedures like urethral slings are often not indicated. The aim of this study was to evaluate the safety and efficacy of a specific radiofrequency (RF) protocol in patients with residual PPI.
Study design, materials and methods
We enrolled 20 patients who underwent RARP for prostate adenocarcinoma at least one year prior, presenting with persistent mild-to-moderate incontinence (assessed via pad test) despite having completed at least 10 sessions of PFMT (Kegel, biofeedback, and probe stimulation) without benefit. The experimental protocol consisted of 15 RF sessions divided into two phases (external and endocavitary).
•	Sessions 1-10: 1) External: static automatic mode (500 kHz, 10 min); 2) Endocavitary: dynamic neutral mode (athermal 1, 450 kHz, 10 min).
•	Sessions 11-15: 1) External: static automatic mode (500 kHz, 10 min); 2) Endocavitary: dynamic neutral mode (continuous, 500 kHz, 10 min).
Treatment parameters monitored included impedance (Ohm), instantaneous output voltage (Vrms)—titrated based on patient tolerance—and total energy transferred (Jtot). Clinical outcomes were assessed via PC-test, pad test, tissue quality evaluation, PSA levels at 6 months, and QoL questionnaires.
Results
The treatment was well-tolerated by all patients with no adverse oncological events (stable PSA). We observed a progressive improvement in tissue impedance, which stabilized at approximately 50 Ohm by the end of the protocol. There was a significant improvement in tissue quality and PC-test scores.
Interpretation of results
Regarding continence recovery:
•	4 patients (20%) achieved complete resolution of incontinence.
•	14 patients (70%) reported improved QoL and reduced pad use.
•	2 patients, who entered the study with moderate-to-severe incontinence (off-label indication for comparison), did not benefit and were subsequently referred for surgical sling/sphincter implantation.
Concluding message
Radiofrequency appears to be a safe and viable "middle-ground" therapeutic option for patients with mild post-RARP incontinence who have failed traditional rehabilitation. By improving tissue impedance and quality, RF can bridge the gap between conservative management and invasive surgery. Further studies are needed to standardize Vrms titration based on individual tissue response.
References
  1. Lord, H. E., et al. Transurethral radiofrequency energy collagen micro-remodeling for the treatment of female stress urinary incontinence.
  2. Ficarra, V., et al. (2012). Retrospective and prospective studies reporting perioperative outcomes of robot-assisted radical prostatectomy. European Urology.
  3. Sadeghi-Nejad, H. (2007). Radiofrequency energy for the treatment of stress urinary incontinence. International Journal of Impotence Research.
Disclosures
Funding none Clinical Trial No Subjects Human Ethics not Req'd already existing treatment Helsinki not Req'd no Informed Consent Yes AI For simple textual assistance in writing the abstract manuscript
Citation

Continence 19S (2026) 102774
DOI: 10.1016/j.cont.2026.102774

22/10/2026 17:46:44